Get started
Author

Yasutaka Kakinoki

Observed names: Y Kakinoki, Y. KAKINOKI, Y. Kakinoki, Yasutaka KAKINOKI
Observed institutions: Hokkaido University, Charles University, Japanese Red Cross Society, Japan, Asahikawa City Hospital, Sapporo Hokuyu Hospital, Sapporo City General Hospital, Asahikawa Kosei Hospital, Kyoaikai Hospital, University of Virginia, Nagoya University
ORCID: 0000-0002-9992-0557
Observed ORCID: 0000-0002-9992-0557
OpenAlex ID: A5013706862
Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial
2020 · Shinya Kimura, Jun Imagawa, et al. · The Lancet Haematology · 112
Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M‐sol)
2008 · Hiroshi Azuma, Junichi Hirayama, et al. · Transfusion · 105
Risk factor analysis of non‐Hodgkin lymphoma‐associated haemophagocytic syndromes: a multicentre study
2014 · Hirozumi Sano, Ryoji Kobayashi, et al. · British Journal of Haematology · 53
Multisite Phosphorylation and the Nuclear Localization of Phosphatase Inhibitor 2-Green Fluorescent Protein Fusion Protein during S Phase of the Cell Growth Cycle
1997 · Yasutaka Kakinoki, Jeremy Somers, et al. · Journal of Biological Chemistry · 45
Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT
2013 · R Kobayashi, J Tanaka, et al. · Bone Marrow Transplantation · 35
High Level of Serum Soluble Interleukin-2 Receptor at Transplantation Predicts Poor Outcome of Allogeneic Stem Cell Transplantation for Adult T Cell Leukemia
2014 · Akio Shigematsu, Naoki Kobayashi, et al. · Transplantation and Cellular Therapy · 30
PDF
Efficacy and safety of Micafungin in Febrile NeutropenicPatients Treated for Hematological Malignancies
2007 · Tomomi Toubai, Junji Tanaka, et al. · Internal Medicine · 30
PDF
Clinical characteristics of the severe acute respiratory syndrome coronavirus 2 omicron variant compared with the delta variant: a retrospective case-control study of 318 outpatients from a single sight institute in Japan
2022 · Keiko Suzuki, Takaya Ichikawa, et al. · PeerJ · 29
High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia
2022 · Hajime Senjo, Masahiro Onozawa, et al. · Scientific Reports · 25
PDF
CD64 Surface Expression on Neutrophils and Monocytes Is Significantly Up-Regulated after Stimulation with Granulocyte Colony-Stimulating Factor during CHOP Chemotherapy for Patients with Non-Hodgkin’s Lymphoma
2004 · Yasutaka Kakinoki, Hiroya Kubota, et al. · International Journal of Hematology · 25
Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic‐phase chronic myeloid leukemia
2018 · Shuichi Ota, Toshihiro Matsukawa, et al. · European Journal Of Haematology · 24
CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review
2015 · Yasutaka Kakinoki, Junichi Hashiguchi, et al. · International Journal of Hematology · 23
A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma
2016 · Satoshi Iyama, Tsutomu Sato, et al. · Clinical Lymphoma Myeloma & Leukemia · 21
Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia
2010 · Misato Kikuchi, Junji Tanaka, et al. · International Journal of Hematology · 21
PDF
A novel nutritional index “simplified CONUT” and the disease risk index independently stratify prognosis of elderly patients with acute myeloid leukemia
2020 · Hajime Senjo, Masahiro Onozawa, et al. · Scientific Reports · 19
PDF
Minimal residual disease (MRD) monitoring using rearrangement of T‐cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients
2005 · Tomomi Toubai, Junji Tanaka, et al. · American Journal of Hematology · 19
PDF
Gene expressions and activities of protein phosphatases PP1 and PP2A in rat liver regeneration after partial hepatectomy
1992 · Yasutaka Kakinoki, Kazuki Kitamura, et al. · Biochemical and Biophysical Research Communications · 18
Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study
2018 · Daisuke Hidaka, Masahiro Onozawa, et al. · Clinical Lymphoma Myeloma & Leukemia · 17
PDF
Tick-borne Disease with Yezo Virus and Borrelia miyamotoi Coinfection
2024 · Keiko Suzuki, Satoshi Suzuki, et al. · Internal Medicine · 14
PDF
Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax‐based therapy in the real world: Hokkaido Leukemia Net Study
2024 · Naoki Miyashita, Masahiro Onozawa, et al. · British Journal of Haematology · 14
PDF
Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for patients with COVID-19 in A Real-Life Setting: A Single Institute Analysis
2022 · Yasutaka Kakinoki, Kazuki Yamada, et al. · International Journal of Infectious Diseases · 14
PDF
Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases
2025 · Takaya Ichikawa, Tomokazu Tamura, et al. · Antiviral Research · 13
Mutations in the nonstructural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in patients with COVID-19
2022 · Takaya Ichikawa, Shiho Torii, et al. · International Journal of Infectious Diseases · 12
PDF
Neoplastic alterations in subcellular distribution of type 1α protein phosphatase in rat ascites hepatoma cells
1995 · Mostafa Saadat, Yusuke Mizuno, et al. · Cancer Letters · 12
Subclinical minute FLT3‐ITD clone can be detected in clinically FLT3‐ ITD‐negative acute myeloid leukaemia at diagnosis
2023 · Shota Yokoyama, Masahiro Onozawa, et al. · British Journal of Haematology · 11
PDF
Works count: 97
Citation count: 907
H-index: 17
I10-index: 28
Year
Topic
Type